DAIKEN MEDICAL, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 6%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Jan 31, 2025 4:00 pm JST Earnings

7775 DAIKEN MEDICAL CO.,LTD 【J-GAAP】

Earnings Report

DAIKEN MEDICAL CO.,LTD <7775> [TSE Std] announced its financial results after the market closed on January 31st (16:00). The ordinary profit (non-consolidated) for the cumulative third quarter of the fiscal year ending March 2025 (April to December) increased 5.9% from the same period last year, reaching 1.31 billion yen. The progress rate toward the full-year plan of 1.5 billion yen was 87.7%, almost the same as the five-year average of 86.2%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary profit for the January to March period (4Q) is expected to decrease 11.1% from the same period last year to 0.18 billion yen.

In the most recent three-month period, from October to December (3Q), the ordinary profit amounted to 0.47 billion yen, a 2.6% decrease compared to the same period last year. The operating profit margin decreased from 19.1% in the same period last year to 17.4%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2022	6,896	969	968	688	24.0	91.9	Jan 31, 2023	J-GAAP
Apr - Dec, 2023	7,406	1,237	1,242	888	30.9	85.7	Jan 31, 2024	J-GAAP
Apr - Dec, 2024	7,665	1,315	1,315	957	33.3	87.7	Jan 31, 2025	J-GAAP
YoY	+3.5%	+6.3%	+5.9%	+7.8%	+7.8%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	4,926	697	700	451	15.7	12	May 15, 2024	J-GAAP
Oct - Mar, 2024 Guidance	5,186	664	664	422	14.7	13	Oct 31, 2024	J-GAAP
YoY	+5.3%	-4.7%	-5.1%	-6.4%	-6.5%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	9,137	1,054	1,053	712	24.8	20	May 15, 2023	J-GAAP
Mar, 2024	9,750	1,442	1,450	988	34.4	21	May 15, 2024	J-GAAP
Mar, 2025 Guidance	10,100	1,500	1,500	1,030	35.9	22	May 15, 2024	J-GAAP
YoY	+3.6%	+4.0%	+3.4%	+4.3%	+4.2%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	2,582	492	492	351	12.2	19.1	Jan 31, 2024	J-GAAP
Jan - Mar, 2024	2,344	205	208	100	3.5	8.7	May 15, 2024	J-GAAP
Apr - Jun, 2024	2,395	397	398	289	10.1	16.6	Jul 31, 2024	J-GAAP
Jul - Sep, 2024	2,519	439	438	319	11.1	17.4	Oct 31, 2024	J-GAAP
Oct - Dec, 2024	2,751	479	479	349	12.2	17.4	Jan 31, 2025	J-GAAP
YoY	+6.5%	-2.6%	-2.6%	-0.6%	-0.6%